Preferred Drug List Review Panel
The NC Medicaid Preferred Drug List (PDL) Review Panel was established by NCDHHS to hold open meetings to discuss recommended policies and procedures related to the PDL as well as address public comments received during the PDL comment period. The administration and review of the NC Medicaid PDL follows the Preferred Drug List Review Panel Guidelines and Procedures.
Upcoming PDL Review Panel Meetings
| Date | Time | Location | Agenda | Attendee Meeting Link | Speaker Registration |
|---|---|---|---|---|---|
| TBD | 1 - 5 p.m. | TBA | Agenda | Link to Attend Virtual Meeting | Speaker Registration Form |
Meeting Archives
Recommendations and Reports
- PDL Annual Report Archive - 2011-2020
PDL Panel Members
Dec. 1, 2022 – July 31, 2024 | ||
|---|---|---|
| Panel Member | Position | Organization |
| Lawrence Greenblatt, MD | Physician | N.C. Physician Advisory Group Pharmacy and Therapeutics Committee |
| Linda Johnson, BSN, RN | Nurse | Research-Based Pharmaceutical Company |
| Brian Shackleford, MD | Physician | Old North State Medical Society |
| Arpit Bhatt, PharmD | Pharmacist | N.C. Association of Pharmacists |
| Aaron Garst, PharmD | Pharmacist | Community Care of North Carolina |
| Anna Miller-Fitzwater, MD | Physician | N.C. Pediatric Society |
| Matt Webber, PharmD | Pharmacist | Hospital-Based Pharmacy |
| Angela B. Smith, PharmD, DHA, FACHE | Pharmacist | Pharmacy Director, Division of Health Benefits |
| Jessica Triche, MD | Physician | N.C. Academy of Family Physicians |
| Duncan Vincent, MD, FACP | Physician | N.C. Chapter of the American College of Physicians |
| Theodore Zarzar, MD | Physician | N.C. Psychiatric Association |
This page was last modified on 09/23/2024